Elanco Announces Public Offering of Common Stock by Selling Shareholder
November 30 2020 - 7:00AM
Business Wire
Elanco Animal Health Incorporated (NYSE: ELAN) announced today
the launch of a public offering of 54,500,000 shares of its common
stock held by Bayer World Investments B.V, an affiliate of Bayer
AG. Bayer World Investments B.V. will be the sole selling
shareholder and will also grant to the underwriters an option to
purchase up to an additional 8,175,000 shares of common stock.
Elanco will not issue shares in the offering and will not receive
any proceeds from the sale of the shares by the selling shareholder
in this offering.
Bayer World Investments B.V. received approximately 72.9 million
shares of Elanco common stock in connection with the completion of
Elanco’s acquisition of the Bayer animal health business on August
1, 2020.
The offering will be made under Elanco’s existing registration
statement on Form S-3 as filed with the Securities and Exchange
Commission. BofA Securities, Goldman Sachs & Co. LLC and Credit
Suisse are the joint book-running managers for the offering.
This press release does not constitute an offer to sell or a
solicitation of an offer to buy these securities, nor does it
constitute an offer, solicitation or sale of these securities in
any jurisdiction in which such offer, solicitation or sale is
unlawful. The offering may be made only by means of a prospectus
and a related prospectus supplement. Copies of the preliminary
prospectus supplement and the accompanying prospectus can be
obtained from: BofA Securities, NC1-004-03-43, 200 North College
Street, 3rd floor, Charlotte, NC 28255-0001, Attention: Prospectus
Department or by email at dg.prospectus_requests@bofa.com; Goldman
Sachs & Co. LLC, Attention: Prospectus Department, 200 West
Street, New York, NY 10282-2198, by telephone at 1-866-471-2526, or
by e-mail at prospectus-ny@ny.email.gs.com; or Credit Suisse
Securities (USA) LLC, Attention: Prospectus Department, 6933 Louis
Stephens Drive, Morrisville, NC 27560, by telephone at
1-800-221-1037 or by email at usa.prospectus@credit-suisse.com.
About Elanco
Elanco Animal Health (NYSE: ELAN) is a global leader in animal
health dedicated to innovating and delivering products and services
to prevent and treat disease in farm animals and pets, creating
value for farmers, pet owners, veterinarians, stakeholders and
society as a whole. With nearly 70 years of animal health heritage,
we are committed to helping our customers improve the health of
animals in their care, while also making a meaningful impact on our
local and global communities. At Elanco, we’re driven by our vision
of Food and Companionship Enriching life and our Elanco Healthy
Purpose™ CSR framework – all to advance the health of animals,
people and the planet.
Forward-Looking Statements
This press release contains forward-looking statements (as that
term is defined in the Private Securities Litigation Reform Act of
1995) about Elanco’s current expectations and assumptions regarding
the proposed offering, capital market conditions, its business and
other future conditions. Forward-looking statements are based on
our current expectations and assumptions regarding our business and
other future conditions. Because forward-looking statements relate
to the future, by their nature, they are subject to inherent
uncertainties, risks and changes in circumstances that are
difficult to predict. As a result, our actual results may differ
materially from those contemplated by the forward-looking
statements. For further discussion of these and other risks and
uncertainties, see Elanco’s most recent filings with the United
States Securities and Exchange Commission. Except as required by
law, Elanco undertakes no duty to update forward-looking statements
to reflect events after the date of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201130005495/en/
Media: Colleen Parr Dekker +1.317.989.7011
colleen_parr_dekker@elanco.com Investor Relations: Tiffany Kanaga
+1.302.897.0668 kanaga_tiffany@elanco.com
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Jul 2023 to Jul 2024